Dextroamp Saccharate/amp Aspartate/dextroamp Sulfate/amp Sulfate Generic Name & Formulations
Legal Class
CII
General Description
Mixed salts of a single-entity amphetamine product (each tab contains equal parts dextroamphetamine saccharate, dextroamphetamine sulfate, amphetamine aspartate monohydrate, amphetamine sulfate); 5mg, 7.5mg, 10mg, 12.5mg, 15mg, 20mg, 30mg; double-scored tabs.
Pharmacological Class
CNS stimulant.
See Also
How Supplied
Caps—100; Tabs—contact supplier.
Manufacturer
Dextroamp Saccharate/amp Aspartate/dextroamp Sulfate/amp Sulfate Indications
Indications
Attention deficit hyperactivity disorder.
Dextroamp Saccharate/amp Aspartate/dextroamp Sulfate/amp Sulfate Dosage and Administration
Adults and Children
Avoid late evening doses; give upon awakening and 4–6hrs apart. <3yrs: not recommended. 3–5yrs: initially 2.5mg once daily, may increase by 2.5mg/day weekly. ≥6yrs: initially 5mg 1–2 times daily, may increase by 5mg/day weekly; usual max 40mg/day in 2–3 divided doses.
Dextroamp Saccharate/amp Aspartate/dextroamp Sulfate/amp Sulfate Contraindications
Contraindications
Advanced arteriosclerosis. Symptomatic cardiovascular disease. Moderate to severe hypertension. Hyperthyroidism. Glaucoma. History of drug abuse. Agitation. During or within 14 days of MAOIs. Hypersensitivity to sympathomimetics.
Dextroamp Saccharate/amp Aspartate/dextroamp Sulfate/amp Sulfate Boxed Warnings
Boxed Warning
Abuse and dependence.
Dextroamp Saccharate/amp Aspartate/dextroamp Sulfate/amp Sulfate Warnings/Precautions
Warnings/Precautions
High potential for abuse and dependence (monitor). Increased risk of sudden death, stroke, and MI; assess for presence of cardiac disease before initiating (eg, family history, physical exam). Avoid in known structural cardiac abnormalities, cardiomyopathy, serious arrhythmias, coronary artery disease, and other cardiac problems. Pre-existing psychotic disorder. Bipolar disorder; screen for risk before initiation. Consider discontinuing if new psychotic/manic symptoms occur. Monitor for new or worsening aggressive behavior or hostility. Seizure disorder. Monitor for serotonin syndrome; discontinue if occurs. Evaluate for tics or Tourette's syndrome prior to therapy. Peripheral vasculopathy, including Raynaud's phenomenon; monitor for digital changes. Monitor growth (esp. children), BP, HR. Renal impairment. Write ℞ for smallest practical amount. Reevaluate periodically. Pregnancy. Nursing mothers: not recommended.
Dextroamp Saccharate/amp Aspartate/dextroamp Sulfate/amp Sulfate Pharmacokinetics
See Literature
Dextroamp Saccharate/amp Aspartate/dextroamp Sulfate/amp Sulfate Interactions
Interactions
See Contraindications. Hypertensive crisis with MAOIs (including linezolid, IV methylene blue). Increased risk of serotonin syndrome with serotonergic drugs (eg, SSRIs, SNRIs, TCAs, triptans, fentanyl, lithium, tramadol, tryptophan, busprione, St. John's wort), CYP2D6 inhibitors (eg, paroxetine, fluoxetine, quinidine, ritonavir); consider alternatives; if needed, initiate with lower doses and monitor. Potentiated by urinary alkalinizers (eg, sodium bicarbonate, acetazolamide); avoid. Antagonized by acidifiers (eg, ascorbic acid). May potentiate TCAs, sympathomimetics, norepinephrine, meperidine; adjust dose or use alternatives. May antagonize adrenergic blockers, antihistamines, antihypertensives, phenobarbital, phenytoin, veratrum alkaloids, ethosuximide. Monitor effects with concomitant PPIs.
Dextroamp Saccharate/amp Aspartate/dextroamp Sulfate/amp Sulfate Adverse Reactions
Adverse Reactions
Anorexia, insomnia, abdominal pain, emotional lability, vomiting, nervousness, nausea, fever, weight loss; also Adults: dry mouth, headache, anxiety, agitation, dizziness, tachycardia, diarrhea, asthenia, UTIs, prolonged erections; hypertension, visual disturbances.
Dextroamp Saccharate/amp Aspartate/dextroamp Sulfate/amp Sulfate Clinical Trials
See Literature
Dextroamp Saccharate/amp Aspartate/dextroamp Sulfate/amp Sulfate Note
Notes
Formerly known under the brand name Adderall.
Dextroamp Saccharate/amp Aspartate/dextroamp Sulfate/amp Sulfate Patient Counseling
See Literature
Dextroamp Saccharate/amp Aspartate/dextroamp Sulfate/amp Sulfate Generic Name & Formulations
Legal Class
CII
General Description
Mixed salts of a single-entity amphetamine product (each tab contains equal parts dextroamphetamine saccharate, dextroamphetamine sulfate, amphetamine aspartate monohydrate, amphetamine sulfate); 5mg, 7.5mg, 10mg, 12.5mg, 15mg, 20mg, 30mg; double-scored tabs.
Pharmacological Class
CNS stimulant.
See Also
How Supplied
Caps—100; Tabs—contact supplier.
Manufacturer
Dextroamp Saccharate/amp Aspartate/dextroamp Sulfate/amp Sulfate Indications
Indications
Narcolepsy.
Dextroamp Saccharate/amp Aspartate/dextroamp Sulfate/amp Sulfate Dosage and Administration
Adults and Children
Avoid late evening doses; give upon awakening and 4–6hrs apart. <12yrs: use dextroamphetamine sulfate; ≥12yrs: usual range 5–60mg/day in divided doses.
Dextroamp Saccharate/amp Aspartate/dextroamp Sulfate/amp Sulfate Contraindications
Contraindications
Advanced arteriosclerosis. Symptomatic cardiovascular disease. Moderate to severe hypertension. Hyperthyroidism. Glaucoma. History of drug abuse. Agitation. During or within 14 days of MAOIs. Hypersensitivity to sympathomimetics.
Dextroamp Saccharate/amp Aspartate/dextroamp Sulfate/amp Sulfate Boxed Warnings
Boxed Warning
Abuse and dependence.
Dextroamp Saccharate/amp Aspartate/dextroamp Sulfate/amp Sulfate Warnings/Precautions
Warnings/Precautions
High potential for abuse and dependence (monitor). Increased risk of sudden death, stroke, and MI; assess for presence of cardiac disease before initiating (eg, family history, physical exam). Avoid in known structural cardiac abnormalities, cardiomyopathy, serious arrhythmias, coronary artery disease, and other cardiac problems. Pre-existing psychotic disorder. Bipolar disorder; screen for risk before initiation. Consider discontinuing if new psychotic/manic symptoms occur. Monitor for new or worsening aggressive behavior or hostility. Seizure disorder. Monitor for serotonin syndrome; discontinue if occurs. Evaluate for tics or Tourette's syndrome prior to therapy. Peripheral vasculopathy, including Raynaud's phenomenon; monitor for digital changes. Monitor growth (esp. children), BP, HR. Renal impairment. Write ℞ for smallest practical amount. Reevaluate periodically. Pregnancy. Nursing mothers: not recommended.
Dextroamp Saccharate/amp Aspartate/dextroamp Sulfate/amp Sulfate Pharmacokinetics
See Literature
Dextroamp Saccharate/amp Aspartate/dextroamp Sulfate/amp Sulfate Interactions
Interactions
See Contraindications. Hypertensive crisis with MAOIs (including linezolid, IV methylene blue). Increased risk of serotonin syndrome with serotonergic drugs (eg, SSRIs, SNRIs, TCAs, triptans, fentanyl, lithium, tramadol, tryptophan, busprione, St. John's wort), CYP2D6 inhibitors (eg, paroxetine, fluoxetine, quinidine, ritonavir); consider alternatives; if needed, initiate with lower doses and monitor. Potentiated by urinary alkalinizers (eg, sodium bicarbonate, acetazolamide); avoid. Antagonized by acidifiers (eg, ascorbic acid). May potentiate TCAs, sympathomimetics, norepinephrine, meperidine; adjust dose or use alternatives. May antagonize adrenergic blockers, antihistamines, antihypertensives, phenobarbital, phenytoin, veratrum alkaloids, ethosuximide. Monitor effects with concomitant PPIs.
Dextroamp Saccharate/amp Aspartate/dextroamp Sulfate/amp Sulfate Adverse Reactions
Adverse Reactions
Anorexia, insomnia, abdominal pain, emotional lability, vomiting, nervousness, nausea, fever, weight loss; also Adults: dry mouth, headache, anxiety, agitation, dizziness, tachycardia, diarrhea, asthenia, UTIs, prolonged erections; hypertension, visual disturbances.
Dextroamp Saccharate/amp Aspartate/dextroamp Sulfate/amp Sulfate Clinical Trials
See Literature
Dextroamp Saccharate/amp Aspartate/dextroamp Sulfate/amp Sulfate Note
Notes
Formerly known under the brand name Adderall.
Dextroamp Saccharate/amp Aspartate/dextroamp Sulfate/amp Sulfate Patient Counseling
See Literature